CX 2019 Presentations

Please note: Some presentations may not be available as permission may not have been given to publish. Sometimes this will include a debate session, during which one speaker has given permission but another speaker has denied it, resulting in the entire session not being uploaded to the website.

Peripheral Proximal Arterial Ischaemia Challenges - Tuesday, 16th April
Venue:   Upper Main Auditorium
Time: 08:00 - 18:00
Imaging
Chairing:   Robert Morgan, President CIRSE, London, United Kingdom
Moderator:   Andrew Holden, Auckland, New Zealand
Paclitaxel: The last word
Chairing:   Roger Greenhalgh, London, United Kingdom
Moderators:   Andrew Holden, Auckland, New Zealand
Gunnar Tepe, Rosenheim, Germany
Thomas Zeller, Bad Krozingen, Germany
Review of paclitaxel usage: The way forward
Chairing:   Roger Greenhalgh, London, United Kingdom
Moderators:   Andrew Holden, Auckland, New Zealand
Gunnar Tepe, Rosenheim, Germany
Thomas Zeller, Bad Krozingen, Germany
Time: 16:00 - 16:30
Edited case: Treating iliac occlusive disease with a covered endoprosthesis - Tuesday, 16th April
Case presenter:   Andrew Holden, Auckland, New Zealand
Time: 17:45 - 17:50
CX Debate: In the absence of suitable venous graft material prosthetic bypass is the answer - Tuesday, 16th April
Against the motion
Time: 17:45 - 17:50
Andrew Holden, Auckland, New Zealand
CLICK HERE TO VIEW VIDEO

Peripheral Critical Ischaemia Challenges - Thursday, 18th April
Venue:   Lower Main Auditorium
Time: 08:00 - 18:00
Time: 10:46 - 10:54
Podium 1st: Intravascular lithoplasty: Study status (DISRUPT PAD II and III) and lessons learnt from a real-world registry - Thursday, 18th April
Speaker:   Andrew Holden, Auckland, New Zealand
Time: 11:22 - 11:30
Podium 1st: Final results of preclinical study comparing drug delivery on 0.018" vs. 0.035" DCB platforms - Thursday, 18th April
Speaker:   Andrew Holden, Auckland, New Zealand
Thoracic Aortic Challenges - Thursday, 18th April
Venue:   Upper Main Auditorium
Time: 08:00 - 18:00
 
Radiation
Chairing:   Dittmar Böckler, President DGG, Heidelberg, Germany
Moderator:   Andrew Holden, Auckland, New Zealand
CX Vascular Access Masterclass - Wednesday, 17th April
Venue:   Pillar Hall Learning Centre
Time: 08:00 - 17:42
Time: 14:49 - 14:57
IN.PACT AV: Baseline data from the full cohort - Wednesday, 17th April
Speaker:   Andrew Holden, Auckland, New Zealand
Time: 14:57 - 15:17
DCBs: Is the data on PVD applicable to vascular access? - Wednesday, 17th April
Panel:   Andrew Holden, Auckland, New Zealand
CX Innovation Showcase - Thursday, 18th April
Venue:   Pillar Hall Learning Centre
Time: 07:30 - 18:00
Time: 09:40 - 09:50
Temporary drug-coated Spur system to address the challenges of DCB technology - Thursday, 18th April
Speaker:   Andrew Holden, Auckland, New Zealand
 
Diagnostic and imaging innovation - Thursday, 18th April
Time: 16:00 - 16:40
Chairing:   Andrew Holden, Auckland, New Zealand
Moderator:   Stephen Greenhalgh, London, United Kingdom
Dragons' Den - Thursday, 18th April
Time: 16:55 - 18:05
Panel:   Andrew Holden, Auckland, New Zealand
Bob Mitchell, Irvine, United States
Peter Phillips, Didcot, United Kingdom
Chas Taylor, Horsham, United Kingdom
Jeffrey Jump, Mont-sur-Rolle, Switzerland
Alan Edwards, Ruthin, United Kingdom
Frans Moll, Utrecht, Netherlands
CX Peripheral Techniques & Technologies (live & edited cases) - Wednesday, 17th April
Venue:   Lower Main Auditorium
Time: 09:30 - 18:00
Time: 10:17 - 10:24
Optimised treatment strategies for post-PTA dissection - Wednesday, 17th April
Speaker:   Andrew Holden, Auckland, New Zealand
Time: 11:00 - 11:30
Edited case: Drug-coated balloon in AV access - Wednesday, 17th April
Speaker:   Andrew Holden, Auckland, New Zealand
Peripheral Arterial Podium 1st Session - Thursday, 18th April
Venue:   Lower Main Auditorium
Time: 10:30 - 12:30
Time: 10:46 - 10:54
Podium 1st: Intravascular lithoplasty: Study status (DISRUPT PAD II and III) and lessons learnt from a real-world registry - Thursday, 18th April
Speaker:   Andrew Holden, Auckland, New Zealand
Time: 11:22 - 11:30
Podium 1st: Final results of preclinical study comparing drug delivery on 0.018" vs. 0.035" DCB platforms - Thursday, 18th April
Speaker:   Andrew Holden, Auckland, New Zealand